| Description |
More than 400 antibody specialists from corporations, drug innovation laboratories, universities, international government agencies and non-profit organizations will participate in the scientific program and their presentations will provide delegates with information on the latest developments in basic, clinical research, and business process directions. Complemented by novel and stimulating sessions and a unique social program, the meeting will inform and entertain and leave delegates inspired for the year ahead
|
|
